Alternative (non-animal) methods for cosmetics testing: current status and future prospects???2010, Archives of Toxicology, vol.277, issue.6, pp.367-485, 2011. ,
DOI : 10.1016/j.tox.2010.08.016
URL : https://hal.archives-ouvertes.fr/ineris-00963274
Formation of steady-state oxygen gradients in vitro:Application to liver zonation, Biotechnology and Bioengineering, vol.73, issue.3, pp.253-262, 2003. ,
DOI : 10.1002/bit.1071
Regional Hepatic CYP1A1 and CYP1A2 Induction with 2,3,7,8-Tetrachlorodibenzo-p-dioxin Evaluated with a Multicompartment Geometric Model of Hepatic Zonation, Toxicology and Applied Pharmacology, vol.144, issue.1, pp.145-155, 1997. ,
DOI : 10.1006/taap.1996.8067
Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes, Biochemical Pharmacology, vol.45, issue.6, pp.1251-1259, 1993. ,
DOI : 10.1016/0006-2952(93)90277-4
Multistage models of carcinogenesis, Environmental Health Perspectives, vol.63, pp.195-201, 1985. ,
DOI : 10.1289/ehp.8563195
Application of Mass Balance Models and the Chemical Activity Concept To Facilitate the Use of in Vitro Toxicity Data for Risk Assessment, Environmental Science & Technology, vol.48, issue.16, pp.9770-9779, 2014. ,
DOI : 10.1021/es501955g
Strategies for the Physiome Project, Annals of Biomedical Engineering, vol.28, issue.8, pp.1043-1058, 2000. ,
DOI : 10.1114/1.1313771
A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of interindividual variability on tissue dosimetry over the human lifespan. Regul, Toxicol. Pharm, vol.57, pp.103-116, 2010. ,
URL : https://hal.archives-ouvertes.fr/ineris-00963225
KNIME: The Konstanz Information Miner, Studies in Classification, Data Analysis, and Knowledge Organization, 2007. ,
DOI : 10.1007/978-3-540-78246-9_38
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment, Regulatory Toxicology and Pharmacology, vol.68, issue.1, pp.119-139, 2014. ,
DOI : 10.1016/j.yrtph.2013.11.008
URL : https://hal.archives-ouvertes.fr/ineris-01855482
Physiologically Based Modelling and Prediction of Drug Interactions, Basic & Clinical Pharmacology & Toxicology, vol.31, issue.9, pp.154-161, 2009. ,
DOI : 10.18637/jss.v002.i09
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals, Toxicology, vol.278, issue.3, pp.256-267, 2010. ,
DOI : 10.1016/j.tox.2010.06.007
URL : https://hal.archives-ouvertes.fr/ineris-00961755
Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches, Toxicology in Vitro, vol.27, issue.5, pp.1570-1577, 2012. ,
DOI : 10.1016/j.tiv.2012.06.012
URL : https://hal.archives-ouvertes.fr/ineris-00963488
Pharmacokinetics and PBPK Models, Comprehensive Toxicology, pp.27-58, 2010. ,
DOI : 10.1016/B978-0-08-046884-6.01505-0
Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing, Toxicology in Vitro, vol.30, issue.1, pp.128-137, 2014. ,
DOI : 10.1016/j.tiv.2014.11.015
URL : https://hal.archives-ouvertes.fr/ineris-01855196
The multistage model with a time-dependent dose pattern: applications to carcinogenic risk assessment, Risk Anal, vol.4, pp.163-176, 1984. ,
Pharmacokinetic???Pharmacodynamic Modelling: History and Perspectives, Journal of Pharmacokinetics and Pharmacodynamics, vol.21, issue.3, pp.227-279, 2006. ,
DOI : 10.1146/annurev.pa.32.040192.001153
Liver tissue engineering in the evaluation of drug safety, Expert Opinion on Drug Metabolism & Toxicology, vol.13, issue.10, pp.1159-1174, 2009. ,
DOI : 10.1039/b901377f
A multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk, Front. Pharmacol, vol.3, p.204, 2013. ,
URL : https://hal.archives-ouvertes.fr/ineris-00961795
A Model for Transport and Dispersion in the Circulatory System Based on the Vascular Fractal Tree, Annals of Biomedical Engineering, vol.31, issue.3, pp.284-293, 2003. ,
DOI : 10.1114/1.1555627
Route-to-Route Extrapolation of the Toxic Potency of MTBE, Risk Analysis, vol.12, issue.2, pp.717-725, 1997. ,
DOI : 10.1080/10590509409373434
How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis, Journal of Hepatology, vol.61, issue.4, pp.951-956, 2014. ,
DOI : 10.1016/j.jhep.2014.06.013
Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients, Toxicology Letters, vol.227, issue.3, pp.189-202, 2014. ,
DOI : 10.1016/j.toxlet.2014.03.013
In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine, Food and Chemical Toxicology, vol.75, pp.39-49, 2015. ,
DOI : 10.1016/j.fct.2014.10.017
Liver zonation: Novel aspects of its regulation and its impact on homeostasis, World Journal of Gastroenterology, vol.20, issue.26, p.8491, 2014. ,
DOI : 10.3748/wjg.v20.i26.8491
Systems biology tools for toxicology, Archives of Toxicology, vol.3, issue.3, pp.1251-1271, 2012. ,
DOI : 10.1006/mben.2001.0187
URL : https://pure.uva.nl/ws/files/1632032/117582_378196.pdf
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats, Integrative Biology, vol.85, issue.1, pp.877-888, 2013. ,
DOI : 10.1177/074823379701300401
URL : https://hal.archives-ouvertes.fr/ineris-00963501
Principles of Route-to-Route Extrapolation for Risk Assessment, 1990. ,
, , 1982.
Organizational principles of the liver The Liver, pp.1-15, 2009. ,
The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics, Chemico-Biological Interactions, vol.168, issue.1, pp.66-73, 2007. ,
DOI : 10.1016/j.cbi.2006.12.003
Systems biology modeling of omics data: effect of cyclosporine a on the Nrf2 pathway in human renal cells, BMC Systems Biology, vol.8, issue.1, p.76, 2014. ,
DOI : 10.1186/1752-0509-8-76
URL : https://hal.archives-ouvertes.fr/ineris-01862454
Quantitative in vitro to in vivo extrapolation of tissues toxicity, Toxicology in Vitro, vol.30, issue.1, pp.203-216, 2015. ,
DOI : 10.1016/j.tiv.2015.01.011
URL : https://hal.archives-ouvertes.fr/ineris-01855034
The virtual liver: a multidisciplinary, multilevel challenge for systems biology, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol.10, issue.3, pp.221-235, 2012. ,
DOI : 10.1038/embor.2009.132
Using an In Silico Liver to evaluate a hepatic enzyme induction mechanism, 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.2415-2418, 2008. ,
DOI : 10.1109/IEMBS.2008.4649686
Integration from proteins to organs: the Physiome Project, Nature Reviews Molecular Cell Biology, vol.28, issue.3, pp.237-243, 2003. ,
DOI : 10.1145/192161.192200
Population-based ADME Simulator, Expert Opinion on Drug Metabolism & Toxicology, vol.45, issue.2, pp.211-223, 2009. ,
DOI : 10.1080/00498250701620726
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data, Drug Metabolism and Disposition, vol.40, issue.5, pp.1007-1017, 2012. ,
DOI : 10.1124/dmd.111.042994
Moving from Basic Toward Systems Pharmacodynamic Models, Journal of Pharmaceutical Sciences, vol.102, issue.9, pp.2930-2940, 2013. ,
DOI : 10.1002/jps.23590
An On-Chip Small Intestine???Liver Model for Pharmacokinetic Studies, Journal of Laboratory Automation, vol.17, issue.3, pp.265-273, 2015. ,
DOI : 10.20965/jrm.2010.p0594
Integrating Cellular Metabolism into a Multiscale Whole-Body Model, PLoS Computational Biology, vol.21, issue.10, 2012. ,
DOI : 10.1371/journal.pcbi.1002750.s001
Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients, Food and Chemical Toxicology, vol.45, issue.12, pp.2533-2562, 2007. ,
DOI : 10.1016/j.fct.2007.06.021
, Molecular Cell Biology, 2000.
Species Extrapolation of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models to Investigate the Developmental Toxicology of Ethanol Using In vitro to In vivo (IVIVE) Methods, Toxicological Sciences, vol.112, issue.2, pp.512-535, 2015. ,
DOI : 10.1016/0002-9378(72)90784-3
Estimation of Membrane Potential and pH Difference across the Cristae Membrane of Rat Liver Mitochondria, European Journal of Biochemistry, vol.38, issue.4, pp.471-484, 1969. ,
DOI : 10.1042/bj0760179
Mutation and Cancer: A Model for Human Carcinogenesis2, JNCI: Journal of the National Cancer Institute, vol.66, issue.6, pp.1037-1052, 1981. ,
DOI : 10.1093/jnci/66.6.1037
Review of QSAR Models and Software Tools for Predicting Biokinetic Properties, JRC Institute for Health and Consumer Protection, 2010. ,
Correlation of structural class with no-observed-effect levels: A proposal for establishing a threshold of concern, Food and Chemical Toxicology, vol.34, issue.9, pp.829-867, 1996. ,
DOI : 10.1016/S0278-6915(96)00049-X
, Toxicity Testing in the 21st Century: A Vision and A Strategy, National Research Council, 2007.
Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts, Trends in Neurosciences, vol.23, issue.4, pp.166-174, 2000. ,
DOI : 10.1016/S0166-2236(99)01534-9
, Toxicological Risk Assessment of Chemicals. Informa Healthcare, 2008.
Zonation of hepatic cytochrome P-450 expression and regulation, Biochemical Journal, vol.329, issue.1, pp.17-35, 1998. ,
DOI : 10.1042/bj3290017
Membrane-Based PDMS Microbioreactor for Perfused 3D Primary Rat Hepatocyte Cultures, Biomedical Microdevices, vol.6, issue.4, pp.279-287, 2004. ,
DOI : 10.1023/B:BMMD.0000048560.96140.ca
Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system, Toxicology Letters, vol.205, issue.3, pp.310-319, 2011. ,
DOI : 10.1016/j.toxlet.2011.06.021
URL : https://hal.archives-ouvertes.fr/ineris-00963306
Multiscale modelling approaches for assessing cosmetic ingredients safety, Toxicology, vol.392, pp.130-139, 2017. ,
DOI : 10.1016/j.tox.2016.05.026
URL : https://hal.archives-ouvertes.fr/ineris-01863940
Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: A case study with acetaminophen, Toxicology Letters, vol.220, issue.1, pp.26-34, 2013. ,
DOI : 10.1016/j.toxlet.2013.03.032
In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling, Mutagenesis, vol.180, issue.6, pp.653-663, 2012. ,
DOI : 10.1016/j.toxlet.2008.05.021
Hepatic clearance of drugs. I. Theoretical considerations of a ???well-stirred??? model and a ???parallel tube??? model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance, Journal of Pharmacokinetics and Biopharmaceutics, vol.36, issue.6, pp.625-653, 1977. ,
DOI : 10.1002/jps.2600640120
Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts, The AAPS Journal, vol.9, issue.2, pp.268-283, 2007. ,
DOI : 10.1208/aapsj0902030
URL : http://europepmc.org/articles/pmc2751417?pdf=render
Physiologically Based Pharmacokinetic (pbpk) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry, 2011. ,
DOI : 10.1002/9781118140291
The successes and failures of physiologically based pharmacokinetic modeling: there is room for improvement, Expert Opinion on Drug Metabolism & Toxicology, vol.18, issue.5, pp.631-635, 2014. ,
DOI : 10.1002/bdd.1776
In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments, Toxicology in Vitro, vol.30, issue.1, pp.36-51, 2014. ,
DOI : 10.1016/j.tiv.2014.12.012
URL : https://hal.archives-ouvertes.fr/hal-01134698
Extrapolating In Vitro Results to Predict Human Toxicity, Vitro Toxicology Systems, pp.531-550, 2014. ,
DOI : 10.1007/978-1-4939-0521-8_24
URL : https://hal.archives-ouvertes.fr/ineris-01852921
R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2013. ,
Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations, Toxicology and Applied Pharmacology, vol.95, issue.2, pp.185-199, 1988. ,
DOI : 10.1016/0041-008X(88)90155-X
Tutorial on physiologically based kinetic modeling in molecular nutrition and food research, Molecular Nutrition & Food Research, vol.1150, issue.6, pp.941-956, 2011. ,
DOI : 10.1002/tera.1420320106
Cloud computing and validation of expandable in silico livers, BMC Systems Biology, vol.4, issue.1, p.168, 2010. ,
DOI : 10.1186/1752-0509-4-168
URL : https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/1752-0509-4-168?site=bmcsystbiol.biomedcentral.com
In vitro models for liver toxicity testing, vitro models for liver toxicity testing, pp.23-39, 2013. ,
DOI : 10.1038/nbt.1554
URL : http://europepmc.org/articles/pmc3593300?pdf=render
BK/TD models for analyzing in vitro impedance data on cytotoxicity, BK/TD models for analyzing in vitro impedance data on cytotoxicity, pp.96-106, 2015. ,
DOI : 10.1016/j.toxlet.2015.03.011
URL : https://hal.archives-ouvertes.fr/hal-01146616
Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regul, Toxicol. Pharm, vol.70, pp.629-640, 2014. ,
DOI : 10.1016/j.yrtph.2014.09.009
URL : https://doi.org/10.1016/j.yrtph.2014.09.009
Quantitative modeling of selective lysosomal targeting for drug design, European Biophysics Journal, vol.3, issue.8, pp.1317-1328, 2008. ,
DOI : 10.1111/j.1365-2818.1991.tb03175.x
URL : http://europepmc.org/articles/pmc2711917?pdf=render
Understanding the biokinetics of ibuprofen after single and repeated treatments in rat and human in vitro liver cell systems, Toxicology Letters, vol.233, issue.2, pp.172-186, 2015. ,
DOI : 10.1016/j.toxlet.2015.01.006
URL : https://hal.archives-ouvertes.fr/hal-01134674
, Next Generation Risk Assessment: Incorporation of Recent Advances in Molecular, Computational, and Systems Biology, 2014.
The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair, Physiological Reviews, vol.89, issue.4, pp.1269-1339, 2009. ,
DOI : 10.1016/0026-2862(73)90051-4
Simulating Microdosimetry in a Virtual Hepatic Lobule, PLoS Computational Biology, vol.128, issue.4, 2010. ,
DOI : 10.1371/journal.pcbi.1000756.t003
Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs, Journal of Pharmacokinetics and Pharmacodynamics, vol.38, issue.2, pp.401-431, 2007. ,
DOI : 10.5414/CPP38053
Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress, Journal of Proteomics, vol.79, pp.180-194, 2013. ,
DOI : 10.1016/j.jprot.2012.11.022
URL : https://hal.archives-ouvertes.fr/ineris-00963456
The Use of Computational Methods in the Toxicological Assessment of Chemicals in Food: Current Status and Future Prospects, JRC Institute for Health and Consumer Protection, 2011. ,
Applicability of the Threshold of Toxicological Concern (TTC) Approach to Cosmetics?Preliminary Analysis, JRC Institute for Health and Consumer Protection, 2012. ,
Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity, Toxicology in Vitro, vol.20, issue.6, pp.995-1004, 2006. ,
DOI : 10.1016/j.tiv.2005.12.008
A Biology-based Dynamic Approach for the Modelling of Toxicity in Cell-based Assays. Part I: Fate Modelling, JRC Institute for Health and Consumer Protection, 2010. ,
A Biology-based Dynamic Approach for the Modelling of Toxicity in Cell Assays. Part II: Models for Cell Population Growth and Toxicity, JRC Institute for Health and Consumer Protection, 2011. ,